In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro)

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the “COVID-19” disease that has been declared by WHO as a global emergency. The pandemic, which emerged in China and widespread all over the world, has no specific treatment till now. The reported antiviral activities of isoflav...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 26; no. 9; p. 2806
Main Authors Alesawy, Mohamed S., Abdallah, Abdallah E., Taghour, Mohammed S., Elkaeed, Eslam B., H. Eissa, Ibrahim, Metwaly, Ahmed M.
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 10.05.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the “COVID-19” disease that has been declared by WHO as a global emergency. The pandemic, which emerged in China and widespread all over the world, has no specific treatment till now. The reported antiviral activities of isoflavonoids encouraged us to find out its in silico anti-SARS-CoV-2 activity. In this work, molecular docking studies were carried out to investigate the interaction of fifty-nine isoflavonoids against hACE2 and viral Mpro. Several other in silico studies including physicochemical properties, ADMET and toxicity have been preceded. The results revealed that the examined isoflavonoids bound perfectly the hACE-2 with free binding energies ranging from −24.02 to −39.33 kcal mol−1, compared to the co-crystallized ligand (−21.39 kcal mol–1). Furthermore, such compounds bound the Mpro with unique binding modes showing free binding energies ranging from −32.19 to −50.79 kcal mol–1, comparing to the co-crystallized ligand (binding energy = −62.84 kcal mol–1). Compounds 33 and 56 showed the most acceptable affinities against hACE2. Compounds 30 and 53 showed the best docking results against Mpro. In silico ADMET studies suggest that most compounds possess drug-likeness properties.
AbstractList The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the “COVID-19” disease that has been declared by WHO as a global emergency. The pandemic, which emerged in China and widespread all over the world, has no specific treatment till now. The reported antiviral activities of isoflavonoids encouraged us to find out its in silico anti-SARS-CoV-2 activity. In this work, molecular docking studies were carried out to investigate the interaction of fifty-nine isoflavonoids against hACE2 and viral M pro . Several other in silico studies including physicochemical properties, ADMET and toxicity have been preceded. The results revealed that the examined isoflavonoids bound perfectly the hACE-2 with free binding energies ranging from −24.02 to −39.33 kcal mol −1 , compared to the co-crystallized ligand (−21.39 kcal mol –1 ). Furthermore, such compounds bound the M pro with unique binding modes showing free binding energies ranging from −32.19 to −50.79 kcal mol –1 , comparing to the co-crystallized ligand (binding energy = −62.84 kcal mol –1 ). Compounds 33 and 56 showed the most acceptable affinities against hACE2. Compounds 30 and 53 showed the best docking results against M pro . In silico ADMET studies suggest that most compounds possess drug-likeness properties.
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the “COVID-19” disease that has been declared by WHO as a global emergency. The pandemic, which emerged in China and widespread all over the world, has no specific treatment till now. The reported antiviral activities of isoflavonoids encouraged us to find out its in silico anti-SARS-CoV-2 activity. In this work, molecular docking studies were carried out to investigate the interaction of fifty-nine isoflavonoids against hACE2 and viral Mpro. Several other in silico studies including physicochemical properties, ADMET and toxicity have been preceded. The results revealed that the examined isoflavonoids bound perfectly the hACE-2 with free binding energies ranging from −24.02 to −39.33 kcal mol−1, compared to the co-crystallized ligand (−21.39 kcal mol–1). Furthermore, such compounds bound the Mpro with unique binding modes showing free binding energies ranging from −32.19 to −50.79 kcal mol–1, comparing to the co-crystallized ligand (binding energy = −62.84 kcal mol–1). Compounds 33 and 56 showed the most acceptable affinities against hACE2. Compounds 30 and 53 showed the best docking results against Mpro. In silico ADMET studies suggest that most compounds possess drug-likeness properties.
Author Taghour, Mohammed S.
Alesawy, Mohamed S.
Abdallah, Abdallah E.
Elkaeed, Eslam B.
Metwaly, Ahmed M.
H. Eissa, Ibrahim
AuthorAffiliation 4 Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt; ametwaly@azhar.edu.eg
1 Medicinal Pharmaceutical Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt; Abdulla_emara@azhar.edu.eg (A.E.A.); Mohammad1533.el@azhar.edu.eg (M.S.T.)
3 Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt
2 Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia; ikaeed@mcst.edu.sa
AuthorAffiliation_xml – name: 1 Medicinal Pharmaceutical Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt; Abdulla_emara@azhar.edu.eg (A.E.A.); Mohammad1533.el@azhar.edu.eg (M.S.T.)
– name: 3 Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt
– name: 2 Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia; ikaeed@mcst.edu.sa
– name: 4 Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt; ametwaly@azhar.edu.eg
Author_xml – sequence: 1
  givenname: Mohamed S.
  orcidid: 0000-0001-9202-1754
  surname: Alesawy
  fullname: Alesawy, Mohamed S.
– sequence: 2
  givenname: Abdallah E.
  surname: Abdallah
  fullname: Abdallah, Abdallah E.
– sequence: 3
  givenname: Mohammed S.
  orcidid: 0000-0003-0630-709X
  surname: Taghour
  fullname: Taghour, Mohammed S.
– sequence: 4
  givenname: Eslam B.
  orcidid: 0000-0002-2546-8035
  surname: Elkaeed
  fullname: Elkaeed, Eslam B.
– sequence: 5
  givenname: Ibrahim
  orcidid: 0000-0002-6955-2263
  surname: H. Eissa
  fullname: H. Eissa, Ibrahim
– sequence: 6
  givenname: Ahmed M.
  orcidid: 0000-0001-8566-1980
  surname: Metwaly
  fullname: Metwaly, Ahmed M.
BookMark eNplkslqHDEQhpvgEC_JA-QmyMU-TCK19kvAdLw02Ngwjq9C1tLW0C1NpG5D3iEPHTljQkxO9VP111dUUYfNXkzRNc1HBD9jLOGXKY3OLKMrLYOyFZC9aQ4QaeEKQyL3_tH7zWEpGwhbRBB91-xjApmgXB40v_oI1mEMJoH1vNjgCkgerNPkQF-SH_VTiinYAnQBt2l2cQ56BJ2ONlg9V7cedIhlBt3Nff9thSS403lwc4gDuFwmHcFpd9aC48fncAJqH7gPuSKuaxu4zRWpiwPH19ucTt43b70ei_vwEo-a7-dnd93l6urmou9Or1aGcDiv-AMxRDookOESVSWYJ5oJZz1iljuHvddaCymIkC2xzGBGuUOItcTVM-Gjpt9xbdIbtc1h0vmnSjqoP4mUB6XzHMzoFOWec4mxF8IQSCsWeUEpk8xTQa2trK871nZ5mJw19UJ1vVfQ15UYHtWQnpRALUNMVMCnF0BOPxZXZrVJS451f9VSDBHliJPqQjuXyamU7PzfCQiq52dQ_z0D_g3coqi0
CitedBy_id crossref_primary_10_1007_s12272_021_01354_2
crossref_primary_10_1080_07391102_2024_2304676
crossref_primary_10_3390_pr10030530
crossref_primary_10_3390_vaccines11020228
crossref_primary_10_3390_metabo12111122
crossref_primary_10_3390_plants11141886
crossref_primary_10_1039_D3RA04007K
crossref_primary_10_1016_j_clnesp_2021_09_728
crossref_primary_10_1002_ardp_202100359
crossref_primary_10_3390_molecules27041216
crossref_primary_10_1155_2022_7270094
crossref_primary_10_1016_j_rechem_2022_100355
crossref_primary_10_3390_nu14030633
crossref_primary_10_3390_molecules26206151
crossref_primary_10_1155_2021_5529786
crossref_primary_10_1186_s12906_023_04303_2
crossref_primary_10_3390_molecules27051636
crossref_primary_10_1080_14786419_2023_2261069
crossref_primary_10_3390_ijms23158407
crossref_primary_10_1080_14756366_2021_2017911
crossref_primary_10_1016_j_molstruc_2024_139082
crossref_primary_10_1177_17475198231221253
crossref_primary_10_1155_2021_5541876
crossref_primary_10_3390_life12091407
crossref_primary_10_1038_s41598_023_47170_0
crossref_primary_10_1016_j_compbiolchem_2023_107928
crossref_primary_10_1177_13596535231199838
crossref_primary_10_3390_ijms23136912
crossref_primary_10_3390_microorganisms10122321
crossref_primary_10_3390_plants11152072
crossref_primary_10_1007_s11130_024_01159_w
crossref_primary_10_1155_2022_5403757
crossref_primary_10_1007_s10562_023_04276_4
crossref_primary_10_1080_14786419_2023_2294111
crossref_primary_10_1016_j_heliyon_2024_e24005
crossref_primary_10_3390_molecules26216593
crossref_primary_10_3390_molecules27030865
crossref_primary_10_1016_j_sjbs_2021_06_044
crossref_primary_10_1007_s11030_023_10702_x
crossref_primary_10_1016_j_compbiolchem_2023_107953
crossref_primary_10_3390_molecules27072281
crossref_primary_10_1371_journal_pone_0299696
crossref_primary_10_1007_s11101_022_09845_w
crossref_primary_10_1038_s41598_022_09809_2
crossref_primary_10_1016_j_compbiolchem_2023_107958
crossref_primary_10_3390_molecules27072287
Cites_doi 10.1016/j.molstruc.2016.10.052
10.1002/9780470744307.gat079
10.1021/ci049903s
10.1016/j.bmc.2017.01.015
10.1056/NEJMe2018715
10.1007/s00134-020-05985-9
10.3164/jcbn.19-70
10.3390/molecules24213911
10.1016/S0014-5793(02)03640-2
10.1016/j.bioorg.2019.103115
10.1155/2021/5542455
10.1038/nrd.2015.37
10.1016/j.tetlet.2014.04.085
10.1055/s-0034-1382393
10.4103/pm.pm_361_18
10.1126/science.abb2762
10.1128/JVI.79.23.14614-14621.2005
10.1016/S0169-409X(96)00423-1
10.1016/S0031-9422(01)00417-4
10.3390/molecules24101856
10.1016/j.antiviral.2006.07.003
10.1056/NEJMoa030781
10.1002/ardp.201900123
10.1186/gb-2003-4-8-225
10.1007/s00044-017-1889-7
10.1007/s12010-017-2426-3
10.1007/978-1-4939-3609-0_9
10.1111/j.1539-6924.1992.tb00709.x
10.3390/biom11030460
10.1021/bk-1994-0546.ch026
10.1016/j.molstruc.2018.04.010
10.1016/j.tim.2016.03.003
10.1038/s41598-021-82550-4
10.4103/ijp.IJP_115_20
10.21608/ajps.2019.64111
10.1194/jlr.D001065
10.1016/bs.aivir.2019.08.002
10.1007/978-1-4899-2913-6_5
10.1080/1062936X.2014.977819
10.1055/s-0035-1556218
10.1016/j.bmc.2017.07.015
10.1016/j.biotechadv.2011.05.021
10.4103/pm.pm_232_20
10.1021/jm0303195
10.1016/S0039-6257(01)00211-9
10.1038/s41467-020-18319-6
10.1126/science.abb3405
10.1016/j.phytol.2013.09.001
10.1177/095632029700800609
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.3390/molecules26092806
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList
Publicly Available Content Database

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X7
  name: ProQuest_Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_57f77933f88c405aaa1f855696f585dd
10_3390_molecules26092806
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
0R~
123
2WC
3V.
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACIWK
ACPRK
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EMOBN
ESTFP
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
HZ~
I09
IAO
ITC
KB.
KQ8
LK8
M1P
M7P
MODMG
M~E
O-U
O9-
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RPM
SV3
TR2
TUS
UKHRP
~8M
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PQEST
PQUKI
PRINS
RIG
5PM
ID FETCH-LOGICAL-c470t-7b4c49e081c79149e86f4a68edf16d7ee3ffaaa89848924d6c3657e11624e2803
IEDL.DBID RPM
ISSN 1420-3049
IngestDate Tue Oct 22 15:12:32 EDT 2024
Tue Sep 17 21:29:08 EDT 2024
Fri Nov 22 10:39:37 EST 2024
Fri Dec 06 09:07:58 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-7b4c49e081c79149e86f4a68edf16d7ee3ffaaa89848924d6c3657e11624e2803
ORCID 0000-0001-8566-1980
0000-0001-9202-1754
0000-0002-2546-8035
0000-0002-6955-2263
0000-0003-0630-709X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126168/
PMID 34068579
PQID 2530157174
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_57f77933f88c405aaa1f855696f585dd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8126168
proquest_journals_2530157174
crossref_primary_10_3390_molecules26092806
PublicationCentury 2000
PublicationDate 20210510
PublicationDateYYYYMMDD 2021-05-10
PublicationDate_xml – month: 5
  year: 2021
  text: 20210510
  day: 10
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_50
Ksiazek (ref_9) 2003; 348
Ayyad (ref_43) 2017; 1130
ref_55
ref_53
ref_51
Zumla (ref_1) 2016; 15
ref_19
ref_17
ref_16
Metwaly (ref_21) 2014; 80
Lipinski (ref_38) 1997; 23
Yassin (ref_23) 2017; 182
Metwaly (ref_20) 2017; 26
Ibrahim (ref_42) 2017; 25
ref_28
Ghoneim (ref_29) 2019; 15
Metwaly (ref_26) 2014; 55
Zhang (ref_5) 2020; 368
Arthan (ref_33) 2002; 59
Tait (ref_36) 2006; 72
Yang (ref_13) 2020; 11
Elbendary (ref_48) 2019; 91
Sperstad (ref_18) 2011; 29
Metwaly (ref_25) 2015; 7
Goodrnan (ref_52) 1992; 12
Jia (ref_15) 2005; 79
ref_32
Venkatapathy (ref_56) 2004; 44
Harmer (ref_10) 2002; 532
Eissa (ref_45) 2019; 352
Hegazy (ref_30) 2021; 17
ref_39
Sharaf (ref_24) 2021; 11
Ibrahim (ref_44) 2017; 25
Ichihara (ref_8) 2010; 51
Horio (ref_35) 2020; 66
Zhang (ref_14) 2020; 46
Su (ref_2) 2016; 24
Metwaly (ref_22) 2019; 59
ref_46
Saad (ref_47) 2018; 1166
Yan (ref_11) 2020; 367
Okubo (ref_34) 1993; Volume 546
Desideri (ref_37) 1997; 8
Xia (ref_49) 2004; 47
Prajapat (ref_6) 2020; 52
Tortorici (ref_12) 2019; Volume 105
ref_41
ref_40
ref_3
Manganelli (ref_54) 2015; 26
Orazbekov (ref_31) 2015; 81
Metwaly (ref_27) 2014; 7
Riordan (ref_7) 2003; 4
Wilhelmus (ref_57) 2001; 45
ref_4
References_xml – volume: 1130
  start-page: 333
  year: 2017
  ident: ref_43
  article-title: Design, synthesis, molecular modeling and biological evaluation of novel 2, 3-dihydrophthalazine-1, 4-dione derivatives as potential anticonvulsant agents
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2016.10.052
  contributor:
    fullname: Ayyad
– ident: ref_51
  doi: 10.1002/9780470744307.gat079
– volume: 44
  start-page: 1623
  year: 2004
  ident: ref_56
  article-title: Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction
  publication-title: J. Chem. Inf. Comput. Sci.
  doi: 10.1021/ci049903s
  contributor:
    fullname: Venkatapathy
– volume: 25
  start-page: 1496
  year: 2017
  ident: ref_42
  article-title: Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists
  publication-title: Bioorganic Med. Chem.
  doi: 10.1016/j.bmc.2017.01.015
  contributor:
    fullname: Ibrahim
– ident: ref_4
  doi: 10.1056/NEJMe2018715
– volume: 46
  start-page: 586
  year: 2020
  ident: ref_14
  article-title: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-05985-9
  contributor:
    fullname: Zhang
– ident: ref_39
– volume: 66
  start-page: 36
  year: 2020
  ident: ref_35
  article-title: Induction of a 5-lipoxygenase product by daidzein is involved in the regulation of influenza virus replication
  publication-title: J. Clin. Biochem. Nutr.
  doi: 10.3164/jcbn.19-70
  contributor:
    fullname: Horio
– ident: ref_17
  doi: 10.3390/molecules24213911
– volume: 532
  start-page: 107
  year: 2002
  ident: ref_10
  article-title: Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
  publication-title: Febs Lett.
  doi: 10.1016/S0014-5793(02)03640-2
  contributor:
    fullname: Harmer
– volume: 91
  start-page: 103115
  year: 2019
  ident: ref_48
  article-title: Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists
  publication-title: Bioorganic Chem.
  doi: 10.1016/j.bioorg.2019.103115
  contributor:
    fullname: Elbendary
– ident: ref_28
  doi: 10.1155/2021/5542455
– volume: 15
  start-page: 327
  year: 2016
  ident: ref_1
  article-title: Coronaviruses - drug discovery and therapeutic options
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2015.37
  contributor:
    fullname: Zumla
– volume: 55
  start-page: 3478
  year: 2014
  ident: ref_26
  article-title: Antileukemic α-pyrone derivatives from the endophytic fungus Alternaria phragmospora
  publication-title: Tetrahedron Lett.
  doi: 10.1016/j.tetlet.2014.04.085
  contributor:
    fullname: Metwaly
– volume: 80
  start-page: PC11
  year: 2014
  ident: ref_21
  article-title: New antimalarial benzopyran derivatives from the endophytic fungus Alternaria phragmospora
  publication-title: Planta Med.
  doi: 10.1055/s-0034-1382393
  contributor:
    fullname: Metwaly
– ident: ref_41
– volume: 15
  start-page: 232
  year: 2019
  ident: ref_29
  article-title: Biological evaluation and molecular docking study of metabolites from Salvadora Persica L. Growing in Egypt
  publication-title: Pharmacogn. Mag.
  doi: 10.4103/pm.pm_361_18
  contributor:
    fullname: Ghoneim
– volume: 367
  start-page: 1444
  year: 2020
  ident: ref_11
  article-title: Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
  publication-title: Science
  doi: 10.1126/science.abb2762
  contributor:
    fullname: Yan
– volume: 79
  start-page: 14614
  year: 2005
  ident: ref_15
  article-title: ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.23.14614-14621.2005
  contributor:
    fullname: Jia
– volume: 23
  start-page: 3
  year: 1997
  ident: ref_38
  article-title: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(96)00423-1
  contributor:
    fullname: Lipinski
– ident: ref_53
– ident: ref_3
– volume: 59
  start-page: 459
  year: 2002
  ident: ref_33
  article-title: Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum
  publication-title: Phytochemistry
  doi: 10.1016/S0031-9422(01)00417-4
  contributor:
    fullname: Arthan
– ident: ref_16
  doi: 10.3390/molecules24101856
– volume: 72
  start-page: 252
  year: 2006
  ident: ref_36
  article-title: Antiviral activity of substituted homoisoflavonoids on enteroviruses
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2006.07.003
  contributor:
    fullname: Tait
– volume: 348
  start-page: 1953
  year: 2003
  ident: ref_9
  article-title: A novel coronavirus associated with severe acute respiratory syndrome
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMoa030781
  contributor:
    fullname: Ksiazek
– volume: 352
  start-page: 1900123
  year: 2019
  ident: ref_45
  article-title: Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors
  publication-title: Arch. Der Pharm.
  doi: 10.1002/ardp.201900123
  contributor:
    fullname: Eissa
– ident: ref_40
– volume: 4
  start-page: 1
  year: 2003
  ident: ref_7
  article-title: Angiotensin-I-converting enzyme and its relatives
  publication-title: Genome Biol.
  doi: 10.1186/gb-2003-4-8-225
  contributor:
    fullname: Riordan
– volume: 26
  start-page: 1796
  year: 2017
  ident: ref_20
  article-title: New α-Pyrone derivatives from the endophytic fungus Embellisia sp.
  publication-title: Med. Chem. Res.
  doi: 10.1007/s00044-017-1889-7
  contributor:
    fullname: Metwaly
– volume: 182
  start-page: 1675
  year: 2017
  ident: ref_23
  article-title: Induction of apoptosis in human cancer cells through extrinsic and intrinsic pathways by Balanites aegyptiaca furostanol saponins and saponin-coated silvernanoparticles
  publication-title: Appl. Biochem. Biotechnol.
  doi: 10.1007/s12010-017-2426-3
  contributor:
    fullname: Yassin
– ident: ref_55
  doi: 10.1007/978-1-4939-3609-0_9
– volume: 12
  start-page: 525
  year: 1992
  ident: ref_52
  article-title: Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens
  publication-title: Risk Anal.
  doi: 10.1111/j.1539-6924.1992.tb00709.x
  contributor:
    fullname: Goodrnan
– ident: ref_19
  doi: 10.3390/biom11030460
– volume: Volume 546
  start-page: 330
  year: 1993
  ident: ref_34
  article-title: Soybean Saponin and Isoflavonoids
  publication-title: Food Phytochemicals for Cancer Prevention I
  doi: 10.1021/bk-1994-0546.ch026
  contributor:
    fullname: Okubo
– volume: 1166
  start-page: 15
  year: 2018
  ident: ref_47
  article-title: Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2018.04.010
  contributor:
    fullname: Saad
– volume: 24
  start-page: 490
  year: 2016
  ident: ref_2
  article-title: Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
  publication-title: Trends Microbiol.
  doi: 10.1016/j.tim.2016.03.003
  contributor:
    fullname: Su
– volume: 11
  start-page: 1
  year: 2021
  ident: ref_24
  article-title: New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA)
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-82550-4
  contributor:
    fullname: Sharaf
– volume: 52
  start-page: 56
  year: 2020
  ident: ref_6
  article-title: Drug targets for corona virus: A systematic review
  publication-title: Indian J. Pharmacol.
  doi: 10.4103/ijp.IJP_115_20
  contributor:
    fullname: Prajapat
– volume: 59
  start-page: 123
  year: 2019
  ident: ref_22
  article-title: Comparative biological evaluation of four endophytic fungi isolated from nigella sativa seeds
  publication-title: Al-Azhar J. Pharm. Sci.
  doi: 10.21608/ajps.2019.64111
  contributor:
    fullname: Metwaly
– volume: 51
  start-page: 635
  year: 2010
  ident: ref_8
  article-title: Preparation of fatty acid methyl esters for gas-liquid chromatography
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D001065
  contributor:
    fullname: Ichihara
– volume: Volume 105
  start-page: 93
  year: 2019
  ident: ref_12
  article-title: Structural insights into coronavirus entry
  publication-title: Advances in Virus Research
  doi: 10.1016/bs.aivir.2019.08.002
  contributor:
    fullname: Tortorici
– ident: ref_32
  doi: 10.1007/978-1-4899-2913-6_5
– volume: 26
  start-page: 1
  year: 2015
  ident: ref_54
  article-title: Comparison of in silico tools for evaluating rat oral acute toxicity
  publication-title: Sar Qsar Environ. Res.
  doi: 10.1080/1062936X.2014.977819
  contributor:
    fullname: Manganelli
– ident: ref_50
– volume: 81
  start-page: PE10
  year: 2015
  ident: ref_31
  article-title: Antifungal prenylated isoflavonoids from Maclura aurantiaca
  publication-title: Planta Med.
  doi: 10.1055/s-0035-1556218
  contributor:
    fullname: Orazbekov
– ident: ref_46
– volume: 7
  start-page: 322
  year: 2015
  ident: ref_25
  article-title: Two new antileishmanial diketopiperazine alkaloids from the endophytic fungus Trichosporum sp.
  publication-title: Derpharmachemica
  contributor:
    fullname: Metwaly
– volume: 25
  start-page: 4723
  year: 2017
  ident: ref_44
  article-title: Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPARγ and SUR agonists
  publication-title: Bioorganic Med. Chem.
  doi: 10.1016/j.bmc.2017.07.015
  contributor:
    fullname: Ibrahim
– volume: 29
  start-page: 519
  year: 2011
  ident: ref_18
  article-title: Antimicrobial peptides from marine invertebrates: Challenges and perspectives in marine antimicrobial peptide discovery
  publication-title: Biotechnol. Adv.
  doi: 10.1016/j.biotechadv.2011.05.021
  contributor:
    fullname: Sperstad
– volume: 17
  start-page: 6
  year: 2021
  ident: ref_30
  article-title: Biological and chemical evaluation of some African plants belonging to Kalanchoe species: Antitrypanosomal, cytotoxic, antitopoisomerase I activities and chemical profiling using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometer
  publication-title: Pharmacogn. Mag.
  doi: 10.4103/pm.pm_232_20
  contributor:
    fullname: Hegazy
– volume: 47
  start-page: 4463
  year: 2004
  ident: ref_49
  article-title: Classification of kinase inhibitors using a Bayesian model
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0303195
  contributor:
    fullname: Xia
– volume: 45
  start-page: 493
  year: 2001
  ident: ref_57
  article-title: The Draize eye test
  publication-title: Surv. Ophthalmol.
  doi: 10.1016/S0039-6257(01)00211-9
  contributor:
    fullname: Wilhelmus
– volume: 11
  start-page: 1
  year: 2020
  ident: ref_13
  article-title: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-18319-6
  contributor:
    fullname: Yang
– volume: 368
  start-page: 409
  year: 2020
  ident: ref_5
  article-title: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
  publication-title: Science
  doi: 10.1126/science.abb3405
  contributor:
    fullname: Zhang
– volume: 7
  start-page: 1
  year: 2014
  ident: ref_27
  article-title: Nigrosphaerin A a new isochromene derivative from the endophytic fungus Nigrospora sphaerica
  publication-title: Phytochem. Lett.
  doi: 10.1016/j.phytol.2013.09.001
  contributor:
    fullname: Metwaly
– volume: 8
  start-page: 545
  year: 1997
  ident: ref_37
  article-title: Synthesis and anti-picornavirus activity of homo-isoflavonoids
  publication-title: Antivir. Chem. Chemother.
  doi: 10.1177/095632029700800609
  contributor:
    fullname: Desideri
SSID ssj0021415
Score 2.559841
Snippet The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the “COVID-19” disease that has been declared by WHO as a global emergency. The...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 2806
SubjectTerms Binding energy
Binding sites
Coronaviruses
COVID-19
Crystallization
Enzymes
Flavonoids
Glycoproteins
human ACE2
Hydrogen bonds
Isoflavonoids
Ligands
main protease
Metabolites
Molecular docking
Molecular weight
Pharmacokinetics
Physicochemical properties
Plasma
Proteins
Seeds
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Toxicity
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PT51AEN4YL_XSWK3xqTVz8KBNiCws--No6XvxNXmtiT_ijSwwW0kUTHn6V_SP7izwjMSDl55IgIVlv2Hn-2B2hrEjmfBchwoDbjEMBDnIQCN3QSGiCKURpLf9AufFT3l-LX7cJrevSn35mLA-PXA_cCTYnSIbip3WBZELay13OkmkkY6Ybll2s28YrcTUILU4-aX-H2ZMov70oS81iy2xd-P_JY68UJesf8Qwx_GRrxzObJN9HJginPU9_MTWsN5iH9JVgbZt9ndew2V1T1DCEA0IjYPL5gFh3jbu3j43dVOVLdgWLpqlDwui66V-HYuX-bT_t62IHUL662b-PeAGrrqwcHJm0H3bh7N0GsHxnd-cALWDm4o6CgtqBhc-wQO5QDhe0BOdfGbXs-lVeh4MxRUIBhUuA5WLQhgkRlAoQzIJtXTCSo2l47JUiLFzNNjaaKFJo5WyiGWikHMZCfQlrXbYet3UuMvAETxEExRNFVbkkTSxywtulCtCFCrHCfu6Guzssc-hkZH28Mhkb5CZsG8ejpcTffrrbgcZRTYYRfaeUUzYwQrMbHgn2yxKaDJLSL6KCVMjgEc3Gx-pq7su5zbxIMml3vsfvdtnG5GPjOlywB6w9eWfJ_xC1GaZH3ZW_A9J2vcS
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELZaOLQX1NJWXaDVHHqAShHrxPHjhCBly1baFomHuEVOMoZIEANZ-BX90YyzWdqoUk-RnNhxMvbM99njGca-yJQXeqww4hbHkSADGWnkLipFHKM0gvh2OOA8-ymPzsSPi_SiX3Bre7fKpU7sFHXly7BGvhunNBRTIh9i7_YuClmjwu5qn0LjJVvlsZLBpU9Pvj8TLk7WabGTmRC1371ZJJzFljC8CTuKA1vUhewf4Myhl-RfZmfyhq31eBH2FwJ-y15gs85eZcs0be_Y72kDJ_U1CRR6n0DwDk78DcK09e7aPvrG11ULtoVjPw_OQdReFk6zBLJP5Ze2JowI2a_z6beIGzjtnMPJpEG3wg_72WEM21fhsgNUD85r6ijMqBochzAPZAhhe0ZftPOenU0OT7OjqE-xQMJQ43mkClEKg4QLSmWILKGWTlipsXJcVgoxcc5aq40WmphaJctEpgo5l7HAkNjqA1tpfIMfGTiTJAQWFCkMK4pYmsQVJTfKlWMUqsAR-7r82fntIpJGTgwkSCb_RzIjdhDE8fxgCILdFfj7y7yfU3mqnCL1kjitS8Kd1E_udJpKIx2RoKoasa2lMPN-Zrb5n3E0Ymog4MHLhnea-qqLvE1oSHKpN_7f8CZ7HQfPly7G6xZbmd8_4CeCLvPiczc-nwBgBe7x
  priority: 102
  providerName: ProQuest
Title In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro)
URI https://www.proquest.com/docview/2530157174
https://pubmed.ncbi.nlm.nih.gov/PMC8126168
https://doaj.org/article/57f77933f88c405aaa1f855696f585dd
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLbaTtr6Uu2qZeui87CHdhJNDL4-tixZMyldtF6UN8TFbpESqErWX7EfvWMHpqK97QVLBoPhHPydDz4fE_JZcJqpsTQBTc04YAiQgTLUBjkLQyM0Q77tJjjPL8T5Nfu-5Msdwru5MF60n2flSbVan1TlnddW3q_zUacTGy3mMYKSoEKNdskuwm9H0VuWRRGStr8vI-Tzo_V2lVnTYOCu3W_EffI8QhRT3Km3nmCRT9nfizP7KsknsDN9SQ7aeBFOt_16RXZM9Zq8iLtl2t6Q37MKLssVGhRaTSDUFi7rtYFZU9tV-lhXdVk0kDawqDdOHITni91sFkf2sf42LTFGhPjHzexrQDVceXE4Qhr4L_xwGk9COLpzxTFgO7gpsaMwx2awcGkeEAjhaI53dPyWXE8nV_F50C6xgMaQ400gM5YzbTAuyKVGsmSUsCwVyhSWikIaE1mbpqnSiilkaoXII8GloVSEzLiFrd6RvaquzHsCVkcRBgsSB4yUZaHQkc1yqqXNx4bJzAzIl-5hJ_fbTBoJMhBnpOQfIw3ImTPH3wNdEmxfUT_cJq0rJFxaicNLZJXKMe7EflKrOBdaWCRBRTEgh50xk_bNbJKQ45DGkcSyAZE9A_cu1t-Djugzb7eO9-G_W34k-6ETxfj0r4dkb_Pwy3zCqGaTDdGXlxK3avptSJ6dTS4WP7H0th_6LwVD7-d_AOx8_fY
link.rule.ids 230,314,727,780,784,864,885,2102,12056,12765,21388,27924,27925,31719,33373,33744,38516,43310,43600,43805,43895,53791,53793,73745,74035,74302,74412
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgeygXxFNsKTAHDi1S1HXi-HFCbdhqF7rLim6r3iInsdtIbVyahV_Bj2ac9RYiJE6RnNhxMvbM99njGULe85QWciRMRLUZRQwNZCQNtVHJ4thwxZBv-wPOszmfnLHPF-lFWHBrg1vlRid2irpypV8jP4hTHIopkg_28fZ75LNG-d3VkELjIdnykdPTAdk6Gs8X3-4pF0X7tN7LTJDcH9ysU86aFlG88nuKPWvUBe3vIc2-n-Rfhuf4CXkcECMcrkX8lDwwzTOynW0StT0nv6YNnNbXKFIIXoHgLJy6GwPT1tlr_dM1rq5a0C0s3Mq7B2F7mT_P4uk-ll_qGlEiZF_Pp58iqmDZuYejUYNujR8Os3EMe1f-sg9YD85r7CjMsBosfKAHNIWwN8Mv2n9Bzo7Hy2wShSQLKA4xWkWiYCVTBpFBKRTSJSO5ZZpLU1nKK2FMYq3WWirJJHK1ipcJT4WhlMfM-NRWL8mgcY15RcCqJEG4IFBlaFbEXCW2KKkSthwZJgozJB82Pzu_XcfSyJGDeMnk_0hmSI68OO4f9GGwuwJ3d5mHWZWnwgpUMImVskTkif2kVqYpV9wiDaqqIdndCDMPc7PN_4ykIRE9Afde1r_T1Fdd7G3EQ5xyufP_ht-R7clydpKfTOdfXpNHsfeD6SK-7pLB6u6HeYNAZlW8DaP1N8SG80I
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKwEXxFNdKGUOHFqkaOPE8eOE2nRXXWCXFX2ot8hJ7DZSm5Rm4Vf0R3ec9bZESJwiObHjZMae77PHM4R84gnNZShMQLUJA4YGMpCG2qBgUWS4Ysi33QHn2ZwfnrCvZ8mZ939qvVvlek7sJuqyKdwa-ShKUBUTJB9sZL1bxOJg8uX6V-AySLmdVp9O4zHZQKsYRgOysT-eL37e0y-Ktmq1rxkj0R9drdLPmhYRvXL7iz3L1AXw76HOvs_kX0Zo8oI89-gR9lbifkkemfoVeZquk7a9JrfTGo6qSxQveA9BaCwcNVcGpm1jL_Wfpm6qsgXdwqJZOlchbC91Z1sc9cfyc10hYoT0x-n0IKAKjjtXcTRw0K33w146jmDnwl12AevBaYUdhRlWg4UL-oBmEXZm-EW7b8jJZHycHgY-4QKKRoTLQOSsYMogSiiEQupkJLdMc2lKS3kpjImt1VpLJZlE3lbyIuaJMJTyiBmX5uotGdRNbTYJWBXHCB0ETh-a5RFXsc0LqoQtQsNEbobk8_pnZ9eruBoZ8hEnmewfyQzJvhPH_YMuJHZX0NycZ36EZYmwAieb2EpZIArFflIrk4QrbpESleWQbK2Fmflx2mYPWjUkoifg3sv6d-rqoovDjdiIUy7f_b_hj-QJKmr2fTr_9p48i5xLTBf8dYsMlje_zQfENMt82yvrHe-B928
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Silico+Studies+of+Some+Isoflavonoids+as+Potential+Candidates+against+COVID-19+Targeting+Human+ACE2+%28hACE2%29+and+Viral+Main+Protease+%28Mpro%29&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Alesawy%2C+Mohamed+S&rft.au=Abdallah%2C+Abdallah+E&rft.au=Taghour%2C+Mohammed+S&rft.au=Elkaeed%2C+Eslam+B&rft.date=2021-05-10&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=26&rft.issue=9&rft.spage=2806&rft_id=info:doi/10.3390%2Fmolecules26092806&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon